To further verify the diagnostic efficacy of these hub genes, ROC analysis was carried out for TLR2, CYBA, ITGB2 and FCGR2A, which significantly differentiated the AD and HC groups. This evidence concerns the gene FCGR2A and Alzheimer disease.